George Flores

A new platform, ConvoGPT OS, has been unveiled with a bold mission: to eliminate human sales jobs, not just assist them, raising major questions for the future of work.

With a new EV plant in Santa Teresa, GreenPower aims for market dominance while New Mexico pushes its ambitious clean energy and economic development goals.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

A breakthrough liquid biopsy shows over 80% accuracy in finding feline lymphoma, offering a non-invasive screening tool for vets and hope for cat owners.

NeuroSense adds world-renowned expert Prof. Steven Arnold to its board, a major vote of confidence in its multi-target Alzheimer's drug, PrimeC.

With a 432% share price jump and billions in financing lined up, Troilus Gold's Quebec project is becoming a cornerstone of North America's critical minerals.

A new brand is infusing the classic martini with adaptogens, betting on a future where cocktails offer wellness benefits without the alcohol.

With a major acquisition and a volatile stock, all eyes are on ServiceNow's Jan 28 results to prove its AI strategy is delivering real financial growth.

The national civil rights firm promotes four lawyers, bolstering its ranks with diverse experts in victims' rights, LGBTQ+ advocacy, and complex litigation.

Dr. Jesse Ehrenfeld's jump to Aidoc validates enterprise AI's role in medicine, as the tech giant surpasses 100 million patient scans analyzed.

Orthopedic Care Partners hires Rob Scoskie as Chief Development Officer, signaling an aggressive push to expand its national footprint amid a PE-fueled race.

The 2026 SR Series G7+ brings revolutionary emergency autoland, seamless connectivity, and luxury refinements to the best-selling piston aircraft.

A $22M short-sea shipping facility in Vancouver is set to slash emissions and ease congestion, unlocking new economic potential for Vancouver Island.

Fintech leader Broadridge completes its acquisition of Acolin, creating an end-to-end solution for asset managers in Europe's complex regulatory maze.

Lexar becomes the global storage partner for the Argentina National Team, a deal uniting tech innovation with football legacy and new fan products.

BridGene Biosciences adds Nobel winner Dr. Bruce Beutler to its board, gaining immense credibility for its mission to create drugs for intractable diseases.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

A new design win for Mobilicom in the UAE highlights the region's rapid shift to autonomous warfare and positions the company for significant growth.

Abingworth elevates Bali Muralidhar and hires Travis Wilson, signaling a major push into clinical co-development and buyouts under Carlyle's wing.

Riot Platforms appoints Jason Chung as CFO, consolidating finance and strategy to accelerate its ambitious expansion into digital infrastructure and AI data centers.